[1]汪晓蓉.小青龙汤联合西药对外寒内饮型AECOPD患者疗效及氧化应激的影响[J].西部中医药,2024,37(08):129-133.[doi:10.12174/j.issn.2096-9600.2024.08.29]
 WANG Xiaorong.Influence of Xiaoqinglong Tang Combined with Western Medicine on Clinical Effects of Patients with AECOPD of External Cold and Internal Drink Pattern and Oxidative Stress[J].Western Journal of Traditional Chinese Medicine,2024,37(08):129-133.[doi:10.12174/j.issn.2096-9600.2024.08.29]
点击复制

小青龙汤联合西药对外寒内饮型AECOPD患者疗效及氧化应激的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年08期
页码:
129-133
栏目:
临床研究
出版日期:
2024-08-15

文章信息/Info

Title:
Influence of Xiaoqinglong Tang Combined with Western Medicine on Clinical Effects of Patients with AECOPD of External Cold and Internal Drink Pattern and Oxidative Stress
作者:
汪晓蓉
陇西县中医医院,甘肃 陇西 748100
Author(s):
WANG Xiaorong
Longxi County Hospital of Traditional Chinese Medicine, Longxi 748100, China
关键词:
阻塞性肺疾病急性加重期小青龙汤布地奈德混悬液氧化应激临床研究
Keywords:
obstructive pulmonary disease acute exacerbationnebulized budesonide inhalation suspensionoxidative stressclinical study
分类号:
R256.14
DOI:
10.12174/j.issn.2096-9600.2024.08.29
文献标志码:
B
摘要:
目的探讨小青龙汤联合布地奈德混悬液雾化吸入对外寒内饮型慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者肺功能和氧化应激水平的影响。 方法将86例外寒内饮型AECOPD患者随机分为观察组和对照组各43例。两组均予对症基础治疗,对照组予布地奈德混悬液雾化吸入治疗,观察组予小青龙汤联合布地奈德混悬液雾化吸入治疗,两组均治疗4周。比较两组治疗前后慢性阻塞性肺疾病患者自我评估测试(COPD assessment test,CAT)评分、肺功能相关指标[呼气峰流速(peak expiratory flow rate,PEF)、第一秒用力呼气量(forced expiratory volume in one second,FEV1)、第一秒用力肺活量/潮气量比值(first second forced vital capacity/tidal volume,FEV1/FVC)]、血清核因子E2相关因子2(nuclear factor erythroid 2-related factor 2,Nrf2)、活性氧(reactive oxygen species,ROS)、超氧歧化酶(superoxide dismutase,SOD)水平和中性粒/淋巴细胞比(neutrophil to lymphocyte ratio,NLR)、血小板/淋巴细胞比(platelet to lymphocyte ratio,PLR)的变化情况及临床疗效。 结果与治疗前比较,两组治疗后CAT评分均降低(P<0.05),肺功能相关指标增加(P<0.05),血清Nrf2、SOD水平升高(P<0.05),ROS水平及NLR、PLR值均降低(P<0.05);治疗后观察组上述各指标改善程度均大于对照组(P<0.05);总有效率观察组[90.47%(38/42)]高于对照组[73.81%(31/42)](P<0.05)。 结论小青龙汤联合布地奈德混悬液雾化吸入治疗能有效改善外寒内饮型AECOPD患者肺功能,降低中性粒细胞比例,减轻氧化应激反应,提高临床疗效。
Abstract:
ObjectiveTo discuss the influence of Xiaoqinglong Tang joined with nebulized budesonide inhalation suspension on pulmonary function and the levels of oxidative stress in patients suffering acute exacerbation of chronic obstructive pulmonary disease (AECOPD) of exterior cold and interior drink pattern. MethodsAll 86 patients were randomized into the observation group and the control group with 43 cases in each group. Both groups accepted symptomatic basic treatment, the control group was given budesonide suspension for nebulized inhalation treatment, and the observation group was treated by Xiaoqinglong Tang and nebulized budesonide inhalation suspension, both groups were treated for four weeks. To compare the changes of CAT scores, pulmonary function related indexes including PEF, FEV1, FEV1/FVC, the levels of Nrf2, ROS, SOD and NLR, PLR, and clinical effects of the two groups before and after the treatment. ResultsCompared with before treating, CAT scores of both groups were lowered after treating (P<0.05), pulmonary function related indexes were increased (P<0.05), the levels of Nrf2 and SOD were raised (P<0.05), the levels of ROS, NLR and PLR were reduced (P<0.05); after the treatment, the above indexes of the observation group were greater than these of the control group (P<0.05); total effective rate of the observation group was [90.47%(38/42)], higher than [73.81%(31/42)] of the control group (P<0.05). ConclusionXiaoqinglong Tang joined with nebulized budesonide inhalation suspension could effectively improve pulmonary function, reduce the proportion of the neutrophils, relieve oxidative stress and improve clinical effects.

相似文献/References:

[1]王兰娣,潘文.沙美特罗替卡松联合益气养阴合剂治疗轻症及缓解期COPD36例[J].西部中医药,2012,25(05):76.
 WANG Lan-di,PAN Wen.Treatment for 36 Cases of Chronic Obstructive Pulmonary Disease at Mild and Remission Stages with Salmeterol Fluticasone and Mixture of Replenishing Qi and Nourishing Yin[J].Western Journal of Traditional Chinese Medicine,2012,25(08):76.
[2]郑引水,马国义.曲安奈德注射液穴位注射治疗慢性阻塞性肺病急性加重期 35 例[J].西部中医药,2014,27(08):115.
[3]许振林,许正龙,贾永兰,等.慢肺饮氧动雾化吸入治疗慢性阻塞性肺疾病137例[J].西部中医药,2013,26(09):5.
 XU Zhenlin,XU Zhenglong,JIA Yonglan,et al.Treatment for 137 Cases of Chronic Obstructive Pulmonary Disease with Oxygen Atomizing Inhalation of ManFei Drink[J].Western Journal of Traditional Chinese Medicine,2013,26(08):5.
[4]李娜,张中新,李双霞.火龙督脉铺灸治疗慢性阻塞性肺疾病稳定期42例[J].西部中医药,2013,26(09):98.
 LI Na,ZHANG Zhongxin,LI Shuangxia.Treating 42 Cases of Chronic Obstructive Pulmonary Disease at Stationary Phase with Fire Dragon Therapy of Long-snake Moxibustion along Governor Meridian[J].Western Journal of Traditional Chinese Medicine,2013,26(08):98.
[5]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
 YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(08):96.
[6]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96.
 SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(08):96.
[7]古立新,李长文.中西医结合疗法治疗AECOPD合并呼吸衰竭45例[J].西部中医药,2017,30(12):1.
 GU Lixin,LI Changwen.Combined Treatment of TCM and Western Medicine in Treating 45 Cases of AECOPD Complicated with Respiratory Failure[J].Western Journal of Traditional Chinese Medicine,2017,30(08):1.
[8]惠朋利,李英,贺鹏.苏黄止咳胶囊联合噻托溴铵治疗慢性阻塞性肺疾病46例[J].西部中医药,2018,31(12):80.
 HUI Pengli,LI Ying,HE Peng.SuHuang Cough-stopping Capsules and Tiotropium Bromide in Treating 46 Cases of Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(08):80.
[9]魏睿,由丽娜,夏杰,等.慢性阻塞性肺疾病中医“寒饮”证患者报告结局量表的信度与效度评价[J].西部中医药,2021,34(02):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
 WEI Rui,YOU Lina,XIA Jie,et al.Evaluation of Reliability and Validity of CFS-COPD-PRO for COPD patients of "Cold and Fluid" Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(08):80.[doi:10.12174/j.issn.2096-9600.2021.02.22]
[10]陈茜,刘伟,姜华,等.参苓白术散联合氨茶碱片治疗慢性阻塞性肺疾病的临床疗效[J].西部中医药,2020,33(06):95.[doi:10.12174/j.issn.1004-6852.2020.06.25]
 CHEN Xi,LIU Wei,JIANG Hua,et al.A Study on Clinical Effects of Shenling Baizhu Powder Combined with Aminophylline Tablets in Treating COPD[J].Western Journal of Traditional Chinese Medicine,2020,33(08):95.[doi:10.12174/j.issn.1004-6852.2020.06.25]
[11]李英梅,刘莉.中医护理对慢性阻塞性肺疾病急性加重期患者的干预效果研究[J].西部中医药,2014,27(10):148.
[12]尹加亮,童佳兵.中药配方颗粒治疗痰热阻肺型慢性阻塞性肺疾病急性加重期患者的有效性和安全性[J].西部中医药,2021,34(06):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
 YIN Jialiang,TONG Jiabing.Evaluation of the Safety and Effectiveness of Herbal Granules in the Treatment of Acute Exacerbation of COPD of Phlegm-heat Obstracting Lung Pattern[J].Western Journal of Traditional Chinese Medicine,2021,34(08):89.[doi:10.12174/j.issn.2096-9600.2021.06.21]
[13]陈炜,张念志,朱福生.四子温肺汤治疗慢性阻塞性肺疾病急性加重期痰湿蕴肺证患者临床观察[J].西部中医药,2023,36(10):125.[doi:10.12174/j.issn.2096-9600.2023.10.26]
 CHEN Wei,ZHANG Nianzhi,ZHU Fusheng.Clinical Observation on Sizi Wenfei Decoction in the Treatment of Acute Exacerbation COPD of Phlegm-dampness Accumulation in the Lung Pattern[J].Western Journal of Traditional Chinese Medicine,2023,36(08):125.[doi:10.12174/j.issn.2096-9600.2023.10.26]

备注/Memo

备注/Memo:
汪晓蓉(1980—),女,副主任医师。研究方向:呼吸系统疾病的中医诊治。E-mail:358856853@qq.com。
更新日期/Last Update: 2024-08-15